Intervention helps kids stay active after cancer treatment

Print Friendly, PDF & Email


Child with leukemia
Photo by Bill Branson
Results of a pilot study suggest a web-based, reward-driven intervention can motivate adolescent cancer survivors to stay physically active. Time spent performing moderate-to-vigorous physical activity (MVPA) increased by an average of 5 minutes a week for subjects who were randomized to the intervention. For control subjects,... [Read Article]
Print Friendly, PDF & Email

Child’s cancer diagnosis can affect mother’s income long-term

Print Friendly, PDF & Email


Child with cancer
Photo by Bill Branson
A study conducted in Sweden revealed that social benefits can ease financial burdens for parents of children recently diagnosed with cancer. However, the study also showed that mothers experienced persistently lower income after benefits diminished. Ayako Hiyoshi, PhD, of Örebro University in Örebro, Sweden, and her... [Read Article]
Print Friendly, PDF & Email

Team recommends changes to trial guidelines

Print Friendly, PDF & Email


Doctor and patient
Photo courtesy of NIH
Researchers have recommended changes to international guidelines used in the development of clinical trials. Their goal is to improve the use of patient-reported outcomes (PROs)—feedback from patients about how the clinical trial has affected their overall health and quality of life. “Patient-reported outcome data from clinical trials... [Read Article]
Print Friendly, PDF & Email

Interim trial results may be misleading

Print Friendly, PDF & Email


Researchers in the lab
Photo by Rhoda Baer
Interim results from randomized trials may be misleading at times, according to research published in JAMA. Researchers compared interim and final publications on randomized trials and found that, 21% of the time, results changed significantly. “Changes between interim and final publication matter because clinicians and... [Read Article]
Print Friendly, PDF & Email

Zika vaccine candidate receives fast track designation

Print Friendly, PDF & Email


A colorized transmission
electron microscopic
image of Zika virus
Image from Cynthia
Goldsmith/CDC
The US Food and Drug Administration (FDA) has granted fast track designation to TAK-426, a candidate vaccine for Zika virus. TAK-426 is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate being developed by Takeda Pharmaceutical Company Limited with the... [Read Article]
Print Friendly, PDF & Email